Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis

Abstract

Normal human cells can either synthesize cholesterol or take it up from lipoproteins to meet their metabolic requirements. In some malignant cells, de novo cholesterol synthesis genes are transcriptionally silent or mutated, meaning that cholesterol uptake from lipoproteins is required for survival. Recent data suggest that lymphoma cells dependent upon lipoprotein-mediated cholesterol uptake are also subject to ferroptosis, an oxygen- and iron-dependent cell death mechanism triggered by accumulation of oxidized lipids in cell membranes unless the lipid hydroperoxidase, glutathione peroxidase 4 (GPX4), reduces these toxic lipid species. To study mechanisms linking cholesterol uptake with ferroptosis and determine the potential role of the high-density lipoprotein (HDL) receptor as a target for cholesterol depleting therapy, we treated lymphoma cell lines known to be sensitive to the reduction of cholesterol uptake with HDL-like nanoparticles (HDL NPs). HDL NPs are a cholesterol-poor ligand that binds to the receptor for cholesterol-rich HDLs, scavenger receptor type B1 (SCARB1). Our data reveal that HDL NP treatment activates a compensatory metabolic response in treated cells toward increased de novo cholesterol synthesis, which is accompanied by nearly complete reduction in expression of GPX4. As a result, oxidized membrane lipids accumulate, leading to cell death through a mechanism consistent with ferroptosis. We obtained similar results in vivo after systemic administration of HDL NPs in mouse lymphoma xenografts and in primary samples obtained from patients with lymphoma. In summary, targeting SCARB1 with HDL NPs in cholesterol uptake–addicted lymphoma cells abolishes GPX4, resulting in cancer cell death by a mechanism consistent with ferroptosis. Normal human cells can either synthesize cholesterol or take it up from lipoproteins to meet their metabolic requirements. In some malignant cells, de novo cholesterol synthesis genes are transcriptionally silent or mutated, meaning that cholesterol uptake from lipoproteins is required for survival. Recent data suggest that lymphoma cells dependent upon lipoprotein-mediated cholesterol uptake are also subject to ferroptosis, an oxygen- and iron-dependent cell death mechanism triggered by accumulation of oxidized lipids in cell membranes unless the lipid hydroperoxidase, glutathione peroxidase 4 (GPX4), reduces these toxic lipid species. To study mechanisms linking cholesterol uptake with ferroptosis and determine the potential role of the high-density lipoprotein (HDL) receptor as a target for cholesterol depleting therapy, we treated lymphoma cell lines known to be sensitive to the reduction of cholesterol uptake with HDL-like nanoparticles (HDL NPs). HDL NPs are a cholesterol-poor ligand that binds to the receptor for cholesterol-rich HDLs, scavenger receptor type B1 (SCARB1). Our data reveal that HDL NP treatment activates a compensatory metabolic response in treated cells toward increased de novo cholesterol synthesis, which is accompanied by nearly complete reduction in expression of GPX4. As a result, oxidized membrane lipids accumulate, leading to cell death through a mechanism consistent with ferroptosis. We obtained similar results in vivo after systemic administration of HDL NPs in mouse lymphoma xenografts and in primary samples obtained from patients with lymphoma. In summary, targeting SCARB1 with HDL NPs in cholesterol uptake–addicted lymphoma cells abolishes GPX4, resulting in cancer cell death by a mechanism consistent with ferroptosis. Despite long-term remission observed in some patients with lymphoma, greater than one-third of patients with the most common subtype, diffuse large B cell lymphoma (DLBCL), will relapse or have disease that is refractory to primary treatment (1Cabanillas F. Shah B. Advances in diagnosis and management of diffuse large B-cell lymphoma.Clin. Lymphoma Myeloma Leuk. 2017; 17: 783-796Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar, 2Hayat M.J. Howlader N. Reichman M.E. Edwards B.K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.Oncologist. 2007; 12: 20-37Crossref PubMed Scopus (764) Google Scholar, 3Heward J.A. Kumar E.A. Korfi K. Okosun J. Fitzgibbon J. Precision medicine and lymphoma.Curr. Opin. Hematol. 2018; 25: 329-334Crossref PubMed Scopus (4) Google Scholar). This is especially the case for patients in high-risk groups identified by molecular and clinical prognostic factors (4Limat S. Daguindau E. Cahn J.Y. Nerich V. Brion A. Perrin S. Woronoff-Lemsi M.C. Deconinck E. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.J. Clin. Pharm. Ther. 2014; 39: 168-174Crossref PubMed Scopus (36) Google Scholar, 5Morimoto Y. Conroy S.M. Ollberding N.J. Henning S.M. Franke A.A. Wilkens L.R. Goodman M.T. Hernandez B.Y. Le Marchand L. Henderson B.E. Kolonel L.N. Maskarinec G. Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.Cancer Cause Control. 2012; 23: 1693-1703Crossref PubMed Scopus (18) Google Scholar). Experimental therapies for these patients, including immunotherapy and cell-based therapies, have modest success rates, high cost, and toxicity (6Harkins R.A. Patel S.P. Flowers C.R. Cost burden of diffuse large B-cell lymphoma.Expert Rev. Pharmacoecon Outcomes Res. PubMed Scopus Google Scholar, M.J. of lymphoma and and Cancer Res. 2018; PubMed Scopus (20) Google Scholar). is a for a identified as a cancer type sensitive to cell death by ferroptosis M.E. K. of cancer cell death by 2014; Full Text Full Text PDF PubMed Scopus Google Scholar). is an iron-dependent of by accumulation of cell membrane lipid and cholesterol that results from the of glutathione peroxidase 4 the of lipid and PubMed Scopus Google Scholar, S. S. K. A. M.E. a cell death linking and 2017; Full Text Full Text PDF PubMed Scopus Google Scholar, Patel of fatty by S. A. PubMed Scopus Google Scholar). to ferroptosis after the reduces and lipid by to lipid M.E. K. of cancer cell death by 2014; Full Text Full Text PDF PubMed Scopus Google Scholar, S. S. K. A. M.E. a cell death linking and 2017; Full Text Full Text PDF PubMed Scopus Google Scholar). cells are sensitive to ferroptosis of of and a to toxic accumulation Patel B. an iron-dependent of cell 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, of cancer cells and PubMed Scopus Google Scholar, Y. M.J. A.A. V. S. cancer cell the and to PubMed Scopus Google Scholar). This in the of to ferroptosis in cancer of have and are toxic and J. L. A. K. V. A. S. S. a cancer cell as 2018; which in vivo and clinical suggest a cholesterol uptake and ferroptosis. of lipoproteins from to large cell lymphoma cell lines and a lymphoma cell ferroptosis J. L. Y. K. B. B. E. G. accumulation in cholesterol cell PubMed Scopus Google Scholar). of these cell lines that a of expression through of or expression through a the cells for S. J. of a in cholesterol synthesis Full Text Full Text PDF PubMed Scopus Google and A. G. J. type of PubMed Scopus Google are required for de novo cholesterol which the for cholesterol In these cholesterol cells, have that of lipoprotein cholesterol uptake by reduction of expression of the receptor the of cells and xenografts in vivo J. L. Y. K. B. B. E. G. accumulation in cholesterol cell PubMed Scopus Google and the cells to ferroptosis by J. L. Y. K. B. B. E. G. accumulation in cholesterol cell PubMed Scopus Google Scholar). data suggest that reduction of cholesterol uptake cells sensitive to the mechanism receptor type is a receptor for cholesterol-rich high-density lipoproteins which as a target in human upon role in cancer cell cholesterol uptake F. J. S. HDL nanoparticles targeting 2018; PubMed Scopus Google Scholar, N. role of cholesterol and cholesterol in a of to cancer PubMed Scopus Google Scholar, S. linking cholesterol and lipoprotein with and PubMed Scopus Google Scholar, V. of cholesterol and in cancer PubMed Scopus Google Scholar, S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, G. N. Y. L. B. L. K. and prognostic of scavenger receptor B type in cell cell 2017; Scopus Google Scholar, N. L. B. L. K. of and as a prognostic in cell cell 2018; PubMed Scopus (20) Google Scholar, S. S. HDL for S. A. Scopus Google Scholar, E. L. S. J. F. high-density lipoproteins as for 2017; PubMed Scopus Google and in S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, lipoprotein by and through and and J. 2018; PubMed Scopus Google Scholar, HDL and in Res. Google Scholar, Y. B. Y. Y. G. F. cell through Ther. PubMed Scopus Google Scholar, S. scavenger receptor B type Res. PubMed Scopus Google factors L. high-density nanoparticles for cancer Rev. Ther. PubMed Scopus (20) Google Scholar, L. high-density nanoparticles as cancer Res. PubMed Scopus Google Scholar, of high-density lipoproteins synthesis of in vivo PubMed Scopus Google Scholar, B. the receptor as a for cancer and PubMed Scopus Google Scholar). Our cholesterol-poor HDL-like nanoparticles (HDL to target and SCARB1 to the uptake of cholesterol from S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar, A. targeting and cholesterol through scavenger receptor type PubMed Scopus Google Scholar). We have that B cell and treatment with the HDL NPs in and in vivo cell death by cholesterol uptake and cell cholesterol S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar, E. L. S. J. F. high-density lipoproteins as for 2017; PubMed Scopus Google Scholar). We have that HDL of cholesterol uptake in sensitive B cell lymphoma cells, including lymphoma cell and cell is accompanied by compensatory in the expression of genes required for de novo cholesterol synthesis S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). We have that lymphoma cells sensitive to HDL cholesterol including B cell lymphoma and cell a high expression of de novo cholesterol genes and cholesterol to the sensitive lymphoma cell lines S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). data are consistent with the by that of the B cell receptor in de novo cholesterol L. S. J. B. A. dependent and cholesterol in diffuse large B cell 23: Full Text Full Text PDF PubMed Scopus Google Scholar). In the case of the lymphoma cells, data that cell death can be with a of HDL NPs and of S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). targeting of SCARB1 by HDL NPs with reduction of cell cholesterol uptake and compensatory in de novo cholesterol is a potential for treatment of cholesterol lymphoma. HDL NP targeting SCARB1 lymphoma cell death through a mechanism and ferroptosis. we a as an to study in expression by HDL NPs in a cholesterol lymphoma cell data that HDL NPs expression of de novo cholesterol which is accompanied by Our data that expression to an in lipids and cell death through a mechanism consistent with ferroptosis in cell in an in vivo and in primary samples obtained from patients with lymphoma. We that and cells, of and SCARB1 S. S. HDL for S. A. Scopus Google Scholar). data that HDL NPs target SCARB1 in and cells, which in cholesterol and in and in vivo cell death S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar). we the of SCARB1 as a target of HDL NPs in these lymphoma cells an and HDL HDL NPs the as S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. high-density nanoparticles as a for 2018; PubMed Scopus Google Scholar). and cells treated with HDL NPs for by HDL NP treatment increased the in cell lines and which by with the SCARB1 by an and HDL NP treatment of cells, a cell cell in increased that the HDL NPs target SCARB1 in B cell lymphoma. We and cell lines SCARB1 and sensitive to HDL cell cell lines and and the cell SCARB1 HDL NP treatment cell death in B cell lymphoma cell the cell of HDL NP to SCARB1 an SCARB1 cell lines from HDL cell death in a and the SCARB1 in cell death in HDL cell death cholesterol-rich have to SCARB1 and of human of a high lipoprotein by the Full Text PDF PubMed Google we HDL NPs also to the in the and cells and HDL cell death to their of an A. lipoprotein uptake of acid and through 2018; PubMed Scopus (20) Google Scholar, B. Y. de S. J. de de and lipoprotein to the receptor 2014; Full Text Full Text PDF PubMed Scopus Google of HDL NPs to and cells, to the observed the SCARB1 and the of SCARB1 and in a reduction in HDL NP with of the SCARB1 and from a of the HDL cell death in or cells and and the of HDL cell death with the SCARB1 and We an study in cells to for in expression that increased cell death by HDL As a we treated cells with either or an of cholesterol-rich human Our data that HDL NP treatment a in the expression of genes in de novo cholesterol as S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google data obtained to the in expression of the de novo cholesterol after treatment with HDL NPs to genes expression we that upon HDL NP treatment We expression and and cells treated with HDL NPs for up to We that HDL NP treatment expression of in cell lines to the B and and and treatment with an of cholesterol-rich or expression S. S. K. A. M.E. a cell death linking and 2017; Full Text Full Text PDF PubMed Scopus Google to ferroptosis from and of cell death with an in oxidized membrane lipids by a that a oxidized and is to lipid and and death can be by of a or an these we HDL NPs ferroptosis in and In cell HDL NP treatment to a in and and cells with HDL NPs in the of either or and for cell of and HDL cell death in and To the role of in HDL cell in cells by an in a by and and As of to HDL NP treatment with and B cell lymphoma cells from HDL cell death with to the of the ferroptosis to malignant as to cells, we HDL NP treatment to in expression or lipid accumulation in primary human we that primary human SCARB1 cell death treated with HDL NPs S. S. HDL for S. A. Scopus Google Scholar). of primary human for or the expression of GPX4, as by in lipid accumulation observed with HDL NP treatment a of cell lines to be for including the cell lines and from lymphoma, of J. L. Y. K. B. B. E. G. accumulation in cholesterol cell PubMed Scopus Google Scholar). cells identified upon in and the cell death by of cholesterol-rich or cells can uptake cholesterol by cholesterol-rich HDL to we expression of SCARB1 in and We SCARB1 expression in and cells accompanied by cell death after treatment with HDL NPs to B cell lymphoma cells, of the SCARB1 of HDL NPs to and cells and HDL cell death of the also HDL NP to the with of the SCARB1 and it HDL cell death of the de novo cholesterol genes in and cells after HDL NP treatment increased and to the B cell lymphoma cell HDL NP treatment expression the and to the in HDL NPs accumulation of lipid in and cells, as by of the ferroptosis and and cells from HDL cell death cell death by ferroptosis. these data that of cholesterol uptake by HDL NP to SCARB1 ferroptosis in identified cholesterol cell We that HDL NPs target and burden in and cells S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar). To determine systemic HDL NP treatment reduces expression and lipid accumulation in cells in we xenografts in in treated with or HDL NPs of HDL for and expression and lipid accumulation by and HDL NP treatment to a of as by with which with an in membrane lipid accumulation observed after systemic administration of HDL data that HDL NPs molecular consistent with ferroptosis in the of lymphoma to be sensitive to HDL NP S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). Our in data suggest that SCARB1 is a to patients with lymphoma be We have data from a of patients with from a that SCARB1 expression increased in with and B cells S. S. HDL for S. A. Scopus Google Scholar). In to SCARB1 expression from primary we of samples In SCARB1 expression in lymphoma also Normal and as and SCARB1 expression observed in samples of and that is a target in patients To determine potential clinical we expression of SCARB1 and HDL NPs cell death in primary B cell lymphoma cells from cells from patients with a diagnosis of lymphoma after a patients to have the large cell lymphoma B cell from and for expression to the samples for lymphoma This in a of B cells and B cell lymphoma As we have B cells SCARB1 S. S. HDL for S. A. Scopus Google Scholar). of the samples of SCARB1 as the of the of and malignant B cells of the primary samples with HDL NPs and for cell death as a of HDL NP the samples upon the lymphoma and of SCARB1 HDL NPs cell death in the B cell lymphoma, and samples of human either or the cells from cell death in In the HDL NPs cell death the and with SCARB1 This is consistent with HDL NPs as for S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). these data that HDL NP B cell lymphoma cell lines can be in primary human B cell lymphoma cells To HDL NPs ferroptosis in the primary B cell lymphoma cells, cells from for lipid accumulation and treatment with HDL NPs HDL NP treatment to an in lipid human HDL treatment of HDL cell death these results that the of HDL NPs to ferroptosis in malignant cells is to cell HDL NPs ferroptosis in primary lymphoma cells obtained from patients with lymphoma. cholesterol-poor HDL NP SCARB1 in cholesterol lymphoma HDL NP to SCARB1 results in a from a cholesterol uptake and high expression to de novo cholesterol which is accompanied by expression of GPX4. As is required by the cancer cell to the burden of membrane lipid peroxidase 4 and PubMed Scopus Google metabolic the cancer cell to the accumulation of oxidized membrane lipids and cell death through a mechanism consistent with ferroptosis. Our data that and expression of is after HDL NP to the receptor for cholesterol-rich high-density and data that HDL NPs of by factors have to a role in expression in M.J. of PubMed Scopus Google including by response A. of expression of the glutathione peroxidase expression and of and Full Text Full Text PDF PubMed Scopus Google and by K. Y. of glutathione peroxidase in human and cells with Res. PubMed Scopus Google Scholar). We have that B cell lymphoma cell cholesterol the of which de novo cholesterol S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). in a and with HDL NPs from in HDL NP treatment of of B cells L. high-density nanoparticles cell and of by receptor PubMed Scopus Google Scholar). are required in to which are to HDL NP Our data a reduction in GPX4, which suggest mechanisms that GPX4. in is in the that of lipid in and of cholesterol in are in of J. L. Y. K. B. B. E. G. accumulation in cholesterol cell PubMed Scopus Google Scholar). of de novo cholesterol expression or ferroptosis K. A. of cell death mechanisms metabolic of 12: PubMed Scopus Google that of de novo cholesterol is ferroptosis and the in mechanism and HDL are required to mechanisms through which the HDL NP in the cholesterol are in the of the and cell lines of their to synthesize cholesterol to by or Our data that HDL NP treatment increased expression of de novo cholesterol synthesis genes and expression of GPX4. In to in the cholesterol that an be ferroptosis in the GPX4. have to in the cholesterol and their and ferroptosis M.E. K. of cancer cell death by 2014; Full Text Full Text PDF PubMed Scopus Google Scholar, S. S. K. A. M.E. a cell death linking and 2017; Full Text Full Text PDF PubMed Scopus Google Scholar, Patel of fatty by S. A. PubMed Scopus Google Scholar, K. A. of cell death mechanisms metabolic of 12: PubMed Scopus Google is HDL NPs a for We have also observed that HDL NP to SCARB1 results in in cell membrane lipid A. targeting and cholesterol through scavenger receptor type PubMed Scopus Google of cell membrane as the case with L. S. J. B. A. dependent and cholesterol in diffuse large B cell 23: Full Text Full Text PDF PubMed Scopus Google Scholar). We have that HDL NPs with of receptor to cell death in S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). it is also that HDL NPs targeting SCARB1 in cholesterol and that also to ferroptosis. Our data suggest that of HDL NPs in cholesterol cell lines is the that these cells can uptake cholesterol the SCARB1 is by the cell lines that the and SCARB1 a role in the cells with as for of human of a high lipoprotein by the Full Text PDF PubMed Google Scholar, S. A. S. of scavenger receptor as a high lipoprotein PubMed Scopus Google HDL NPs can to SCARB1 and the it through SCARB1 that cell death in the B and cell lymphoma cell As and by to HDL to SCARB1 to including the S. by the HDL receptor scavenger receptor B type PubMed Scopus Google Scholar). that a in expression with of B. Y. L. S. ferroptosis in cell PubMed Scopus (4) Google Scholar). As it is that of HDL NPs to SCARB1 cholesterol also that of cholesterol uptake by nanoparticles upon an to be an target in cholesterol or cholesterol In and in the HDL NP as systemic in we have a of toxic S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar, E. L. S. J. F. high-density lipoproteins as for 2017; PubMed Scopus Google Scholar, S. high-density nanoparticles as a for 2018; PubMed Scopus Google Scholar, S. high lipoprotein nanoparticles for acid PubMed Scopus Google Scholar, receptor type B1 and lipoprotein Cancer Ther. 2018; 17: PubMed Scopus Google Scholar). We also that HDL NP treatment of primary human and the most cell that in toxicity and that of the cell cholesterol treated with the HDL NP or human HDL S. S. HDL for S. A. Scopus Google Scholar). with data the toxicity of HDL NPs toward lymphoma cancer cells that have to upon cholesterol uptake and expression to ferroptosis, to the of toxicity is that cells have the burden as the cancer cells and the cells are to with to cholesterol data as HDL NP treatment in human in a reduction in expression or the accumulation of lipid In we that HDL NPs target SCARB1 in cholesterol and lymphoma cells an response an in de novo cholesterol the of results in the death of the cancer cells by ferroptosis As metabolic is to it is that HDL NPs have in a of that are sensitive to cell death by ferroptosis and human cell lines obtained from and of to their cell lines to cells, to for to in cell lines in with serum and in a HDL NPs and as M.C. and of cholesterol to a of high-density Res. Full Text Full Text PDF PubMed Scopus Google Scholar). nanoparticles with by of the and HDL NPs the with a of HDL NPs and To synthesize HDL the a the and of the HDL NPs as and cells with HDL NPs in for in the or of a SCARB1 the with of cell serum and in of to the cells treated with HDL NPs human HDL or for to the samples to by the and the of for by the with a of or and a data are the for as S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar). the SCARB1 the the the and a in these and cells treated with HDL NPs human HDL or for up to and the In an to HDL NPs upon as S. S. HDL for S. A. Scopus Google Scholar). samples a and a to and expression the for and cells treated with HDL NPs or for or to and the cells for cells with in and in the the the as S. S. A. targeting of cholesterol in diffuse large B-cell lymphoma by lipoprotein a dependent cell of Pharm. 2017; PubMed Scopus Google Scholar, S. S. HDL for S. A. Scopus Google Scholar). and cells a of and for to and cells a of and for to SCARB1 and of to and obtained from and a of to expression obtained from in for the a by in the cells a of and with the or by for as S. in B cells after or of Google Scholar). cells for a of to of cells for expression by and and cell HDL NP treatment by as human obtained from and in of with as S. S. HDL for S. A. Scopus Google Scholar). cells a of and to to treatment with HDL treated with or HDL human HDL or for or the cell and analyses for and as the the primary human treated for to of the and by in with and and for an and to for the cells to HDL NP their and HDL NPs of NPs). for and by the and the cells through a to a of the cell and as from the of the cells to expression by as from patients with large B cell lymphoma and lymphoma. samples of than of lymphoma and samples obtained and for SCARB1 of the a SCARB1 by the the Cancer of and as and and lymphoma cells from from patients with B cell in with an and by the in the of of than to after of samples with of lymphoma from and B cell with and through a with and for cells in with and serum and for to to for to SCARB1 and the To cell primary lymphoma cells in the of human or HDL NPs for cells with and and the with the cells as the cell in the and and To ferroptosis in primary cells, cells in the of human HDL or HDL NPs in the or of of as accumulation as in cell with the the primary lymphoma with or treatment and to determine analyses the data are the for data are the the of S. K. and L. G. are of a that the HDL NP from J. S. A. A. E. S. J. A. and A. We the the and the is the of the and the of the of J. S. HDL NPs in in HDL NP primary lymphoma cells, in the in vivo and SCARB1 HDL NP and and in and in vivo ferroptosis A. L. in the primary lymphoma cells and HDL NP K. and A. E. in the in vivo S. Y. with cell and A. B. and primary samples for SCARB1 expression by J. and A. in samples for A. B. and K. in primary lymphoma samples for in J. S. A. S. and L. G. the the and the This by the Cancer Cancer G. and S. the of and for a S. the of for the of of the and the of Cancer S. and the and

Topics & Concepts